139 related articles for article (PubMed ID: 16417272)
21. Labelling of EDTMP (Multibone) with [111In], [99mTc] and [188Re] using different carriers for "cross complexation".
Mitterhauser M; Wadsak W; Eidherr H; Krcal A; Kletter K; Dudczak R; Viernstein H; Pirich C
Appl Radiat Isot; 2004 May; 60(5):653-8. PubMed ID: 15082042
[TBL] [Abstract][Full Text] [Related]
22. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours.
Lambert B; Bacher K; Defreyne L
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309
[TBL] [Abstract][Full Text] [Related]
23. Radiolabeling of dextran with rhenium-188.
Du J; Marquez M; Hiltunen J; Nilsson S; Holmberg AR
Appl Radiat Isot; 2000 Sep; 53(3):443-8. PubMed ID: 10972151
[TBL] [Abstract][Full Text] [Related]
24. Automation of the synthesis of highly concentrated 188Re-MAG3 for intracoronary radiation therapy.
Oh SJ; Moon DH; Ha HJ; Park SW; Hong MK; Park SJ; Choi TH; Lim SM; Choi CW; Knapp FF; Lee HK
Appl Radiat Isot; 2001 Mar; 54(3):419-27. PubMed ID: 11214876
[TBL] [Abstract][Full Text] [Related]
25. The 188Re(III)-EDTA complex--a multipurpose starting material for the preparation of relevant 188Re complexes under mild conditions.
Seifert S; Pietzsch HJ
Appl Radiat Isot; 2006 Feb; 64(2):223-7. PubMed ID: 16198583
[TBL] [Abstract][Full Text] [Related]
26. One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system.
Lee SJ; Oh SJ; Chi DY; Kang SH; Kil HS; Kim JS; Moon DH
Nucl Med Biol; 2007 May; 34(4):345-51. PubMed ID: 17499723
[TBL] [Abstract][Full Text] [Related]
27. Rhenium(V) oxocomplexes with novel pyrazolyl-based N4- and N3S-donor chelators.
Moura C; Vítor RF; Maria L; Paulo A; Santos IC; Santos I
Dalton Trans; 2006 Dec; (47):5630-40. PubMed ID: 17225899
[TBL] [Abstract][Full Text] [Related]
28. Studies on the preparation and isomeric composition of 186Re- and 188Re-pentavalent rhenium dimercaptosuccinic acid complex.
Singh J; Reghebi K; Lazarus CR; Clarke SE; Callahan AP; Knapp FF; Blower PJ
Nucl Med Commun; 1993 Mar; 14(3):197-203. PubMed ID: 8384352
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of rhenium-centric reverse turn mimics.
Hickey JL; Luyt LG
Chemistry; 2012 Oct; 18(41):12999-3007. PubMed ID: 22945687
[TBL] [Abstract][Full Text] [Related]
30. [Production and therapeutic use of rhenium-186, 188--the future of radionuclides].
Vucina J; Han R
Med Pregl; 2003; 56(7-8):362-5. PubMed ID: 14587255
[TBL] [Abstract][Full Text] [Related]
31. Production of 61Cu using natural cobalt target and its separation using ascorbic acid and common anion exchange resin.
Das SS; Chattopadhyay S; Barua L; Das MK
Appl Radiat Isot; 2012 Feb; 70(2):365-8. PubMed ID: 22093183
[TBL] [Abstract][Full Text] [Related]
32. Rhenium-188--a generator-derived radioisotope for cancer therapy.
Knapp FF
Cancer Biother Radiopharm; 1998 Oct; 13(5):337-49. PubMed ID: 10851424
[TBL] [Abstract][Full Text] [Related]
33. Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals.
Chhabra A; Rathore Y; Bhusari P; Vatsa R; Mittal BR; Shukla J
Nucl Med Commun; 2018 Oct; 39(10):957-959. PubMed ID: 30086075
[TBL] [Abstract][Full Text] [Related]
34. Chelating ion-exchange methods for the preparation of no-carrier-added 64Cu.
Watanabe S; Watanabe S; Liang J; Hanaoka H; Endo K; Ishioka NS
Nucl Med Biol; 2009 Aug; 36(6):587-90. PubMed ID: 19647164
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
36. Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC.
Di Pierro D; Rizzello A; Cicoria G; Lodi F; Marengo M; Pancaldi D; Trespidi S; Boschi S
Appl Radiat Isot; 2008 Aug; 66(8):1091-6. PubMed ID: 18226535
[TBL] [Abstract][Full Text] [Related]
37. A convenient solution-phase method for the preparation of meta-iodobenzylguanidine in high effective specific activity.
Donovan AC; Valliant JF
Nucl Med Biol; 2008 Oct; 35(7):741-6. PubMed ID: 18848658
[TBL] [Abstract][Full Text] [Related]
38. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates.
Riddoch RW; Schaffer P; Valliant JF
Bioconjug Chem; 2006; 17(1):226-35. PubMed ID: 16417273
[TBL] [Abstract][Full Text] [Related]
39. Aqueous fluoride and the preparation of [99mTc(CO)3(OH2)3]+ and 99mTc-carborane complexes.
Sogbein OO; Green AE; Valliant JF
Inorg Chem; 2005 Dec; 44(25):9585-91. PubMed ID: 16323948
[TBL] [Abstract][Full Text] [Related]
40. Fully automated synthesis of 4-[18F]fluorobenzylamine based on borohydride/NiCl2 reduction.
Way J; Wuest F
Nucl Med Biol; 2013 Apr; 40(3):430-6. PubMed ID: 23306136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
